King Saud bin Abdulaziz University for Health Sciences is the first public university in the Kingdom of Saudi Arabia and the Middle East region specialized in health sciences. Its headquarters is in the main campus in Riyadh, the capital of Saudi Arabia. It has two other campuses in Jeddah and Al-Ahsa.

During the past decade, King Saud bin Abdulaziz University for Health Sciences conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "King Saud bin Abdulaziz University for Health Sciences" are "Acute Respiratory Failure" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "King Saud bin Abdulaziz University for Health Sciences" in a lesser frequency.

Most popular intervention types in "King Saud bin Abdulaziz University for Health Sciences" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Audiovisual material "video"" (1 trials) and "Printed material "brochure"" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Saud bin Abdulaziz University for Health Sciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "King Saud bin Abdulaziz University for Health Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in King Saud bin Abdulaziz University for Health Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in King Saud bin Abdulaziz University for Health Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".